A unique cell surface antigen identifying lymphoid malignancies of B cell origin.

A monoclonal antibody (anti-B1) specific for a unique B cell surface differentiation antigen was used to characterize the malignant cells from patients with leukemias or lymphomas. All tumor cells from patients with lymphomas or chronic lymphocytic leukemias, bearing either monoclonal kappa lambda l...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Clin Invest
Principais autores:	Nadler, L M, Ritz, J, Hardy, R, Pesando, J M, Schlossman, S F, Stashenko, P
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Clinical Investigation 1981
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC371580/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6969730/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI110005
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!